Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
71.23
-0.13 (-0.18%)
At close: Jul 14, 2026, 4:00 PM EDT
71.23
0.00 (0.00%)
Pre-market: Jul 15, 2026, 7:38 AM EDT

Bio-Techne Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
11,1007,97311,33612,86813,57517,541
Market Cap Growth
34.10%-29.67%-11.91%-5.20%-22.61%72.74%
Enterprise Value
11,1768,25511,60313,11913,64117,738
Last Close Price
71.2351.4571.6581.6386.66112.57
PE Ratio
102.53111.8568.2446.3852.20129.39
Forward PE
35.5525.7436.7236.5739.5561.93
PEG Ratio
7.462.396.483.102.472.90
PS Ratio
9.176.549.7811.3212.2818.84
PB Ratio
5.354.165.486.547.9811.22
P/TBV Ratio
14.1514.3619.5523.6340.85175.38
P/FCF Ratio
41.1731.0848.0159.5348.4256.98
P/OCF Ratio
37.6427.7337.9250.5841.7349.81
EV/Sales Ratio
9.236.7710.0111.5412.3419.05
EV/EBITDA Ratio
30.5338.9136.4432.3034.3054.57
EV/EBIT Ratio
36.0880.7356.1443.8845.9974.75
EV/FCF Ratio
41.4532.1849.1460.6948.6557.62
Debt / Equity Ratio
0.130.220.200.230.180.25
Debt / EBITDA Ratio
1.142.091.321.120.791.29
Debt / FCF Ratio
1.081.731.782.111.121.37
Net Debt / Equity Ratio
0.040.150.130.130.040.12
Net Debt / EBITDA Ratio
0.321.330.840.620.170.58
Net Debt / FCF Ratio
0.301.101.131.160.240.61
Asset Turnover
0.480.460.430.460.490.43
Inventory Turnover
2.092.332.222.352.712.71
Quick Ratio
2.772.102.473.292.512.48
Current Ratio
4.493.463.874.843.443.35
Return on Equity (ROE)
5.35%3.68%8.33%15.57%16.08%9.46%
Return on Assets (ROA)
4.51%2.90%7.00%10.21%11.36%10.42%
Return on Invested Capital (ROIC)
5.26%3.36%8.22%12.65%14.68%13.53%
Return on Capital Employed (ROCE)
6.43%4.15%8.18%12.92%14.03%11.77%
Earnings Yield
0.99%0.89%1.47%2.16%1.92%0.77%
FCF Yield
2.43%3.22%2.08%1.68%2.07%1.76%
Dividend Yield
0.45%0.62%0.45%0.39%0.37%0.28%
Payout Ratio
46.06%68.65%29.99%17.63%18.45%35.34%
Buyback Yield / Dilution
2.32%0.66%0.67%1.38%-1.35%-2.75%
Total Shareholder Return
2.77%1.28%1.11%1.77%-0.98%-2.46%
SEC Filings: 10-K · 10-Q